Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 214

1.

Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.

Ferreira RJ, Kincses A, Gajdács M, Spengler G, Dos Santos DJVA, Molnár J, Ferreira MU.

J Nat Prod. 2018 Sep 10. doi: 10.1021/acs.jnatprod.8b00326. [Epub ahead of print]

PMID:
30199257
2.

In Vitro Evaluation of the Multidrug Resistance Reversing Activity of Novel Imidazo[4,5-b]pyridine Derivatives.

Bourichi S, Misbahi H, Rodi YK, Chahdi FO, Essassi EM, Szabó S, Szalontai B, Gajdács M, Molnár J, Spengler G.

Anticancer Res. 2018 Jul;38(7):3999-4003. doi: 10.21873/anticanres.12687.

PMID:
29970523
3.

Amyloid-beta Interactions with ABC Transporters and Resistance Modifiers.

Molnar J, Ocsovszki I, Pusztai R.

Anticancer Res. 2018 Jun;38(6):3407-3410. doi: 10.21873/anticanres.12608.

PMID:
29848690
4.

A Comparative Study of the ReCell® Device and Autologous Spit-Thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries.

Holmes Iv JH, Molnar JA, Carter JE, Hwang J, Cairns BA, King BT, Smith DJ, Cruse CW, Foster KN, Peck MD, Sood R, Feldman MJ, Jordan MH, Mozingo DW, Greenhalgh DG, Palmieri TL, Griswold JA, Dissanaike S, Hickerson WL.

J Burn Care Res. 2018 Aug 17;39(5):694-702. doi: 10.1093/jbcr/iry029.

5.

Multidrug resistance reversal activity of extract and a rare dimeric naphthoquinone from Diospyros lotus.

Rauf A, Shaheen U, Raza M, Uddin G, Hadda TB, Mabkhot YN, Jehan N, Ahmad B, Raza S, Molnar J, Csonka Á, Szabó D.

Pak J Pharm Sci. 2018 May;31(3):821-825.

PMID:
29716861
6.

Discovery of Novel Enhancers of Isoniazid Toxicity in Mycobacterium tuberculosis.

Lentz F, Reiling N, Martins A, Molnár J, Hilgeroth A.

Molecules. 2018 Apr 4;23(4). pii: E825. doi: 10.3390/molecules23040825.

7.

Extensive Hand Thermal and Blast Injury From Electronic Cigarette Explosion: A Case Report.

Satteson ES, Walker NJ, Tuohy CJ, Molnar JA.

Hand (N Y). 2017 Nov 1:1558944717744333. doi: 10.1177/1558944717744333. [Epub ahead of print]

PMID:
29192506
8.

Possible Biological and Clinical Applications of Phenothiazines.

Varga B, Csonka Á, Csonka A, Molnár J, Amaral L, Spengler G.

Anticancer Res. 2017 Nov;37(11):5983-5993. Review.

PMID:
29061777
9.

Trigger Thumb.

Pencle FJ, Molnar JA.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2017 Jun 15.

10.

Isolation of Chlorogenic Acid from Soil Borne Fungi Screlotium rolfsii, their Reversal of Multidrug Resistance and Anti-proliferative in Mouse Lymphoma Cells.

Ahmad B, Rizwan M, Rauf A, Raza M, Bashir S, Molnar J, Csonka A, Szabo D, Mubarak MS, Noor M, Siddiqui BS.

Med Chem. 2017;13(8):721-726. doi: 10.2174/1573406413666170612110443.

PMID:
28606042
11.

Synthesis and SAR Study of Anticancer Protoflavone Derivatives: Investigation of Cytotoxicity and Interaction with ABCB1 and ABCG2 Multidrug Efflux Transporters.

Dankó B, Tóth S, Martins A, Vágvölgyi M, Kúsz N, Molnár J, Chang FR, Wu YC, Szakács G, Hunyadi A.

ChemMedChem. 2017 Jun 7;12(11):850-859. doi: 10.1002/cmdc.201700225. Epub 2017 May 23.

PMID:
28436164
12.

Exploring Jolkinol D Derivatives To Overcome Multidrug Resistance in Cancer.

Reis MA, Ahmed OB, Spengler G, Molnár J, Lage H, Ferreira MU.

J Nat Prod. 2017 May 26;80(5):1411-1420. doi: 10.1021/acs.jnatprod.6b01084. Epub 2017 Apr 19.

PMID:
28421773
13.

Dregamine and tabernaemontanine derivatives as ABCB1 modulators on resistant cancer cells.

Paterna A, Kincses A, Spengler G, Mulhovo S, Molnár J, Ferreira MU.

Eur J Med Chem. 2017 Mar 10;128:247-257. doi: 10.1016/j.ejmech.2017.01.044. Epub 2017 Feb 1.

PMID:
28189906
14.

Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition.

Hunyadi A, Csábi J, Martins A, Molnár J, Balázs A, Tóth G.

Molecules. 2017 Jan 25;22(2). pii: E199. doi: 10.3390/molecules22020199.

15.

Fluorinated Beta-diketo Phosphorus Ylides Are Novel Efflux Pump Inhibitors in Bacteria.

Kincses A, Szabó ÁM, Saijo R, Watanabe G, Kawase M, Molnár J, Spengler G.

In Vivo. 2016 11-12;30(6):813-817.

PMID:
27815466
16.

The Anticancer Activity of the Old Neuroleptic Phenothiazine-type Drug Thioridazine.

Spengler G, Csonka Á, Molnár J, Amaral L.

Anticancer Res. 2016 Nov;36(11):5701-5706. Review.

PMID:
27793891
18.

Triterpenoids from Momordica balsamina: Reversal of ABCB1-mediated multidrug resistance.

Ramalhete C, Mulhovo S, Molnar J, Ferreira MU.

Bioorg Med Chem. 2016 Nov 1;24(21):5061-5067. doi: 10.1016/j.bmc.2016.08.022. Epub 2016 Aug 20.

PMID:
27591010
19.

Nutrition and Chronic Wounds: Improving Clinical Outcomes.

Molnar JA, Vlad LG, Gumus T.

Plast Reconstr Surg. 2016 Sep;138(3 Suppl):71S-81S. doi: 10.1097/PRS.0000000000002676. Review.

PMID:
27556777
20.

Jatrophane diterpenes and cancer multidrug resistance - ABCB1 efflux modulation and selective cell death induction.

Reis MA, Ahmed OB, Spengler G, Molnár J, Lage H, Ferreira MJ.

Phytomedicine. 2016 Aug 15;23(9):968-78. doi: 10.1016/j.phymed.2016.05.007. Epub 2016 May 24.

PMID:
27387405

Supplemental Content

Loading ...
Support Center